Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.72 |
---|---|
High | 0.72 |
Low | 0.57 |
Bid | 0.6011 |
Offer | 0.678 |
Previous close | 0.7101 |
Average volume | 72.47k |
---|---|
Shares outstanding | 39.54m |
Free float | 10.02m |
P/E (TTM) | -- |
Market cap | 26.81m USD |
EPS (TTM) | -0.4891 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Announcements
- MiNK Therapeutics and Autonomous Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic Tumors
- MiNK Therapeutics to Present Data From iNKT Cell Programs at SITC 2024
- MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference
- MiNK Reports Second Quarter 2024 Results and Business Update
- MiNK Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial Report
- MiNK Therapeutics Regains Compliance with Nasdaq Capital Market Requirement
- MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
- MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting
- MiNK Reports First Quarter 2024 Results
- MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer
More ▼